Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Bafna Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,026	1,769	1,853	1,940	2,996	3,252
Market Cap Growth	-4.53%	-4.53%	-4.45%	-35.25%	-7.86%	10234.58%
Enterprise Value	2,273	1,945	1,941	2,104	3,042	3,275
Last Close Price	85.63	74.80	78.35	82.00	126.65	137.45
PE Ratio	48.65	42.60	25.23	17.11	57.44	55.81
PS Ratio	1.39	1.21	1.22	1.68	3.52	4.57
PB Ratio	2.39	2.09	2.29	2.64	4.84	5.73
P/TBV Ratio	2.39	2.09	2.34	2.70	4.84	5.73
P/FCF Ratio	733.41	640.66	-	-	136.99	-
P/OCF Ratio	9.15	7.99	19.54	39.17	30.80	-
EV/Sales Ratio	1.56	1.33	1.27	1.82	3.57	4.60
EV/EBITDA Ratio	20.34	17.40	16.94	12.30	25.07	30.83
EV/EBIT Ratio	36.16	30.93	30.03	17.88	45.81	53.29
EV/FCF Ratio	823.08	704.05	-	-	139.09	-
Debt / Equity Ratio	0.33	0.33	0.30	0.31	0.18	0.28
Debt / EBITDA Ratio	2.52	2.52	2.13	1.34	0.91	1.49
Debt / FCF Ratio	102.10	102.10	-	-	5.06	-
Asset Turnover	0.97	0.97	1.10	1.05	0.96	0.90
Inventory Turnover	3.57	3.57	4.14	3.62	2.89	3.39
Quick Ratio	0.84	0.84	0.87	1.05	0.68	0.92
Current Ratio	1.66	1.66	1.75	1.88	2.31	2.04
Return on Equity (ROE)	5.01%	5.01%	9.53%	16.74%	8.79%	10.82%
Return on Assets (ROA)	2.61%	2.61%	2.91%	6.70%	4.70%	4.88%
Return on Capital (ROIC)	3.60%	3.60%	4.01%	8.69%	5.70%	6.07%
Return on Capital Employed (ROCE)	6.20%	6.20%	6.90%	14.20%	9.70%	9.90%
Earnings Yield	2.05%	2.35%	3.96%	5.85%	1.74%	1.79%
FCF Yield	0.14%	0.16%	-3.29%	-0.91%	0.73%	-6.06%
Buyback Yield / Dilution	0.24%	0.24%	-	-	0.13%	-901.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.